Skip to main content
Back
ARRJF logo

Arjo AB (publ)

Data quality: 100%
Oversold
ARRJF
OTC Healthcare Medical - Distribution
$2.97
$0.00 (0.00%)
Mkt Cap: 840.21M
Day Range
$2.97 $3.51
52-Week Range
$2.97 $3.51
Volume
325
50D / 200D Avg
$3.17 / $3.19
Prev Close
$2.97

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 2.5 0.4
P/B 0.1 2.9
ROE % 4.2 3.7
Net Margin % 3.0 3.9
Rev Growth 5Y % 4.9 10.0
D/E 0.2 0.2

Analyst Price Target

No analyst coverage available

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2028 $2.64
$2.59 – $2.68
 12 B 1
FY2027 $2.28
$2.24 – $2.31
 11 B 1
FY2026 $1.97
$1.94 – $2.00
 11 B 1

Key Takeaways

Revenue grew 4.94% annually over 5 years — modest growth
Earnings declined -32.93% over the past year
ROE of 4.23% is below average
Debt/Equity of 0.17 — conservative balance sheet
Generating 755.10M in free cash flow
P/E of 2.52 — trading at a low valuation

Growth

Revenue Growth (5Y)
4.94%
Revenue (1Y)-2.59%
Earnings (1Y)-32.93%
FCF Growth (3Y)-28.01%

Quality

Return on Equity
4.23%
ROIC7.14%
Net Margin3.04%
Op. Margin7.55%

Safety

Debt / Equity
0.17
Current Ratio1.83
Interest Coverage3.99

Valuation

P/E Ratio
2.52
P/B Ratio0.11
EV/EBITDA1.53
Dividend Yield0.03%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -2.59% Revenue Growth (3Y) 0.09%
Earnings Growth (1Y) -32.93% Earnings Growth (3Y) -16.58%
Revenue Growth (5Y) 4.94% Earnings Growth (5Y) -18.09%
Profitability
Revenue (TTM) 11.00B Net Income (TTM) 334.00M
ROE 4.23% ROA 2.23%
Gross Margin 39.13% Operating Margin 7.55%
Net Margin 3.04% Free Cash Flow (TTM) 755.10M
ROIC 7.14% FCF Growth (3Y) -28.01%
Safety
Debt / Equity 0.17 Current Ratio 1.83
Interest Coverage 3.99 Dividend Yield 0.03%
Valuation
P/E Ratio 2.52 P/B Ratio 0.11
P/S Ratio 0.08 PEG Ratio -0.76
EV/EBITDA 1.53 Dividend Yield 0.03%
Market Cap 840.21M Enterprise Value 1.27B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 11.00B 11.29B 10.98B 9.98B 9.07B
Net Income 334.00M 498.00M 480.00M 449.00M 742.00M
EPS (Diluted) 1.23 1.83 1.76 1.65 2.72
Gross Profit 4.30B 4.91B 4.74B 4.21B 4.21B
Operating Income 831.00M 893.00M 884.00M 691.00M 1.08B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 14.98B 16.28B 15.44B 16.17B 14.61B
Total Liabilities 7.52B 7.94B 7.86B 8.54B 7.73B
Shareholders' Equity 7.46B 8.34B 7.58B 7.62B 6.89B
Total Debt 1.27B 5.42B 5.49B 6.31B 5.45B
Cash & Equivalents 836.00M 892.00M 923.00M 949.00M 757.00M
Current Assets 4.32B 4.85B 4.42B 5.03B 4.17B
Current Liabilities 2.37B 4.60B 4.40B 4.62B 6.49B

Strategy Scores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#547 of 820
35
Value Defensive Investing (Benjamin Graham)
#155 of 708
47

Recent Activity

Entered Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered Defensive Investing (Benjamin Graham)
Mar 24, 2026